$RLFTF (opinion post) by Victor on Ya-h00 - Friend
Post# of 653
(Total Views: 525)
Posted On: 02/09/2021 2:16:50 PM
$RLFTF (opinion post) by Victor on Ya-h00 - Friends,
I wanted to address todays call, price action and a few other topics from an Internal Medicine/Hospitalist's perspective. A little about me. I have been here since August. I have 40% of my portfolio invest in RLFTF and 50% invested in the BRPA family. I am still here. I work on the front lines, in a smaller rural community hospital with a rather large catchment area. Most days are spent treating the critical COVID patients. I have seen a lot of death and I have seen some miracles.
The data released today is great but incomplete. As I was reviewing the results I was extremely excited as were many colleagues. Prior to COVID-19, my hospital had 14ish ICU beds. We now have 30 active with the ability to flip 10-15 more to ICU if need be. We have had to shut down 2/3 of the hospital to safely place COVID from non COVID. We have the PACU, ED, Observation piled up with patients because we have no place to put the average patient with Afib, HF, MI, and a variety of other bread and butter illnesses. This is mostly due to length of stay and critical needs.
We have grown in our ability to care for COVID-19 and prolong life. This hurts hospital throughput and has deleterious effects on other patients.
Please understand that prolonging life and mortality are just that. Death. I am not at all surprised about similar 28 day mortality results. A lot of these patients are older and have high fragility index scores, and are already beyond the average life expectancy of the US Citizen. The Golden data showed recovery from respiratory failure and significant reduction in ICU stay and Hospital stay. What does that mean?
It means that my patient didn't end up with a lung transplant. They didn't end up with a Tracheostomy. The didn't need to leave the hospital with a portable oxygen tank. They're quality of life is restored.
One could say that 1 day in the ICU mean 1 week in skilled rehab facility. When you reduce length of stay you have reduced recovery time. You reduced significant cost. You have massively reduced the risk of hospital associated infections and death (think about our Firefighter we all loved). You have reduced the risk of errors.
I look at this data with no doubt of EUA. The benefits are clear.
Turning to price action...I'm speechless. There is no reason for it. I can understand that Dr. J and team could have handled the CC better, but the data is good.
I'll leave you with this. I spoke with every one of my partners today. They all want the drug for EUA now. That is telling.
I wanted to address todays call, price action and a few other topics from an Internal Medicine/Hospitalist's perspective. A little about me. I have been here since August. I have 40% of my portfolio invest in RLFTF and 50% invested in the BRPA family. I am still here. I work on the front lines, in a smaller rural community hospital with a rather large catchment area. Most days are spent treating the critical COVID patients. I have seen a lot of death and I have seen some miracles.
The data released today is great but incomplete. As I was reviewing the results I was extremely excited as were many colleagues. Prior to COVID-19, my hospital had 14ish ICU beds. We now have 30 active with the ability to flip 10-15 more to ICU if need be. We have had to shut down 2/3 of the hospital to safely place COVID from non COVID. We have the PACU, ED, Observation piled up with patients because we have no place to put the average patient with Afib, HF, MI, and a variety of other bread and butter illnesses. This is mostly due to length of stay and critical needs.
We have grown in our ability to care for COVID-19 and prolong life. This hurts hospital throughput and has deleterious effects on other patients.
Please understand that prolonging life and mortality are just that. Death. I am not at all surprised about similar 28 day mortality results. A lot of these patients are older and have high fragility index scores, and are already beyond the average life expectancy of the US Citizen. The Golden data showed recovery from respiratory failure and significant reduction in ICU stay and Hospital stay. What does that mean?
It means that my patient didn't end up with a lung transplant. They didn't end up with a Tracheostomy. The didn't need to leave the hospital with a portable oxygen tank. They're quality of life is restored.
One could say that 1 day in the ICU mean 1 week in skilled rehab facility. When you reduce length of stay you have reduced recovery time. You reduced significant cost. You have massively reduced the risk of hospital associated infections and death (think about our Firefighter we all loved). You have reduced the risk of errors.
I look at this data with no doubt of EUA. The benefits are clear.
Turning to price action...I'm speechless. There is no reason for it. I can understand that Dr. J and team could have handled the CC better, but the data is good.
I'll leave you with this. I spoke with every one of my partners today. They all want the drug for EUA now. That is telling.
(1)
(0)Mondobiotech Holding AG Basel (RLFTF) Stock Research Links
$MJ